Pemvidutide
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
Altimmune · Phase 2 · Completed · Enrollment 100
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Pemvidutide 2.4 mg | Alcohol Use Disorder (AUD) | 2.4 mg | n/r | n/r | n/r |
| Placebo | Alcohol Use Disorder (AUD) | n/r | n/r | n/r | n/r |